Broker Recommendations
RBC says Bain's offer the best eSure can expect, for now
Following an unsolicited bid from Bain Capital, analysts at RBC Capital Markets saw fit to take another look at their numbers on online insurer eSure.
Morgan Stanley upgrades BAE Systems on improved earnings visibility
The stars are lining up for BAE Systems, according to analysts at Morgan Stanley, who on Monday upgraded their recommendation for the shares from 'equalweight' to 'overweight' on the back of increased visibility on the company's earnings.
City downgrades Paddy Power Betfair after cutting earnings forecasts
Citigroup cut its estimates for Paddy Power Betfair's future earnings due declining revenues from the exchange business and start-up costs from its burgeoning US business, among other factors.
Liberum upgrades Clarkson to 'buy' after results
Liberum upgraded shipping services company Clarkson to 'buy' from 'hold' on Monday as it said its confidence in the short-term outlook has improved following in-line interim results and signs of firmer current trading.
Berenberg points out upside from Burberry Group's rebranding
Analysts at Berenberg marked-up their target price for shares of Burberry, on the back of changes to their foreign exchange assumptions, from 2,220p to 2,350p.
Barclays downgrades Meggitt, says self-help is in the valuation
Barclays downgraded Meggitt to 'equalweight' from 'overweight' on Monday as it said the company's self-help potential is now reflected in the share price.
Credit Suisse upgrades Paddy Power on 'more reasonable' valuation
Analysts at Credit Suisse upgraded Paddy Power Betfair to 'neutral' on Friday but noted that uncertainty remained around the bookmaker's exchange business and the scale of investments required to get its US operations off the ground.
UBS expects RBS to deliver 'significant special dividends or buybacks'
Royal Bank of Scotland's earnings and excess capital are being undervalued by the market, said UBS on Friday, upgrading the shares to 'buy' from 'neutral'.
Friday broker round-up
Rolls Royce: JP Morgan downgrades to underweight with a target price of 965p.
Liberum cuts Card Factory price target after profit warning
Liberum cut its price target on Card Factory on Friday to 195p from 210p following the greeting cards retailer’s profit warning a day earlier.
Numis and Peel Hunt positive on Cineworld
Analysts at Numis and Peel Hunt reacted positively to Cineworld's latest interims.
Peel Hunt downgrades Card Factory on lack of positive catalysts
Analysts at Peel Hunt downgraded their recommendation for shares of Card Factory, pointing to the 0. 7% drop in company's like-for-like sales over the first half of the year and the lack of any guidance for an improvement from management as the key reasons for the change.
Jefferies ups Capita to 'buy' on software division potential
Shares in outsourcer Capita rallied on Thursday as Jefferies upgraded the stock to 'buy' from 'hold', highlighting the potential of the company's software division.
UBS casts doubt on Smith & Nephew's orthopaedic footprint
A survey of surgeons by UBS has indicated that Smith & Nephew's share of the orthopaedic surgical robots market will not be as big as first thought, leading to analysts downgrading their rating on the shares.
Wednesday broker round-up
Spire Healthcare Group: Berenberg downgrades to sell with a target price of 120p.
Morgan Stanley hikes Inmarsat price target, highlights potential upside
Morgan Stanley has upped its target price for Inmarsat and, while the recent rally in the shares makes the valuation "not particularly appealing", there are variables in the pipeline that could make the shares look cheap.
Credit Suisse slashes Countrywide target after heavily discounted placing
Analysts at Credit Suisse upgraded Countrywide to 'neutral' on Wednesday, but slashed its target price on the London-listed firm from 77p all the way down to 17. 2p.
Spire Healthcare slumps on Berenberg double downgrade
Spire Healthcare was under the cosh on Wednesday as Berenberg cut its stance on the company to 'sell' from 'buy' and slashed the price target to 120p from 290p following the profit warning on Monday.